| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Mary T. Szela | CEO and President | 2026-03-17 | 15,944 | $3.85 | $61.38kSell |
| Bryan F. Cox | Chief of Research | 2026-03-16 | 579 | $4.12 | $2.39kSell |
| Jodi Devlin | Chief of Clinical Operations | 2026-03-16 | 273 | $4.12 | $1.12kSell |
| Jennifer Stevens | Chief Regulatory Officer | 2026-03-16 | 774 | $4.12 | $3.19kSell |
| Richard Marshak | Chief Commercial Officer | 2026-03-16 | 419 | $4.12 | $1.73kSell |
| Richard Marshak | Chief Commercial Officer | 2026-03-12 | 1,589 | $4.09 | $6.50kSell |
| Bryan F. Cox | Chief of Research | 2026-03-12 | 1,467 | $4.09 | $6.00kSell |
| Jodi Devlin | Chief of Clinical Operations | 2026-03-12 | 1,772 | $4.09 | $7.25kSell |
| Jennifer Stevens | Chief Regulatory Officer | 2026-03-12 | 1,552 | $4.09 | $6.35kSell |
| Mary T. Szela | CEO and President | 2026-03-11 | 4,358 | $4.13 | $18.00kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Medtech Acquisition Sponsor LLC | 10.19% | 6,249,999 | $24.50M | Insider |
| Equity Ab Frankenius | 10.16% | 6,230,748 | $24.42M | Insider |
| Mats Wahlstrom | 4.35% | 2,665,202 | $10.45M | Insider |
| Kerry R. Hicks | 3.73% | 2,289,199 | $8.97M | Insider |
| Nantahala Capital Management LLC | 3.38% | 2,070,827 | $8.12M | Institution |
| Blackrock Inc | 2.50% | 1,534,336 | $6.01M | Institution |
| Vanguard Group Inc | 2.50% | 1,530,707 | $6.00M | Institution |
| Awm Investment Company Inc | 2.03% | 1,243,780 | $4.88M | Institution |
| Michael P. Stansky | 1.61% | 986,830 | $3.87M | Insider |
| Gilder Gagnon Howe Co LLC | 1.60% | 979,023 | $3.84M | Institution |